Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.860
-0.050 (-1.72%)
At close: Apr 28, 2026, 4:00 PM EDT
2.880
+0.020 (0.70%)
After-hours: Apr 28, 2026, 7:54 PM EDT
Cabaletta Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 29.57 | 27.94 | 19.24 | 14.84 | 13.82 | |
| Research & Development | 142.67 | 97.2 | 55.42 | 39.3 | 32.49 | |
| Operating Expenses | 172.24 | 125.14 | 74.66 | 54.14 | 46.31 | |
| Operating Income | -172.24 | -125.14 | -74.66 | -54.14 | -46.31 | |
| Interest Expense | -2 | -0.75 | - | - | - | |
| Interest & Investment Income | 6.03 | 10.03 | 6.99 | 1.16 | 0.02 | |
| Other Non Operating Income (Expenses) | 0.36 | - | - | - | - | |
| EBT Excluding Unusual Items | -167.86 | -115.86 | -67.68 | -52.98 | -46.29 | |
| Pretax Income | -167.86 | -115.86 | -67.68 | -52.98 | -46.29 | |
| Net Income | -167.86 | -115.86 | -67.68 | -52.98 | -46.29 | |
| Net Income to Common | -167.86 | -115.86 | -67.68 | -52.98 | -46.29 | |
| Shares Outstanding (Basic) | 80 | 50 | 41 | 29 | 26 | |
| Shares Outstanding (Diluted) | 80 | 50 | 41 | 29 | 26 | |
| Shares Change (YoY) | 61.34% | 20.95% | 39.54% | 14.01% | 11.20% | |
| EPS (Basic) | -2.10 | -2.34 | -1.65 | -1.81 | -1.80 | |
| EPS (Diluted) | -2.10 | -2.34 | -1.65 | -1.81 | -1.80 | |
| Free Cash Flow | -132.31 | -90.43 | -54.24 | -48.83 | -35.28 | |
| Free Cash Flow Per Share | -1.66 | -1.83 | -1.32 | -1.66 | -1.37 | |
| EBITDA | -170.6 | -123.43 | -73.23 | -52.96 | -45.58 | |
| D&A For EBITDA | 1.65 | 1.71 | 1.43 | 1.18 | 0.73 | |
| EBIT | -172.24 | -125.14 | -74.66 | -54.14 | -46.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.